tradingkey.logo

Bridgebio Continues Long Term Debt Management Strategy And Announces Proposed Offering Of Convertible Senior Notes

ReutersJan 14, 2026 9:03 PM

- BridgeBio Pharma Inc BBIO.O:

  • BRIDGEBIO CONTINUES LONG TERM DEBT MANAGEMENT STRATEGY AND ANNOUNCES PROPOSED OFFERING OF CONVERTIBLE SENIOR NOTES DUE 2033 TO PREFUND REPAYMENT OF CONVERTIBLE SENIOR NOTES DUE 2027

  • BRIDGEBIO PHARMA INC - TO OFFER $550 MILLION CONVERTIBLE SENIOR NOTES DUE 2033

  • BRIDGEBIO PHARMA INC - PROCEEDS TO REPURCHASE OR REPAY 2027 NOTES

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI